Expression of heme oxygenase-1, hypoxia inducible factor-1α, and ubiquitin in peripheral inflammatory cells from patients with coronary heart disease

被引:16
作者
Chen, Song-Ming [1 ]
Li, Yu-Guang [1 ]
Wang, Dong-Ming [1 ]
Zhang, Guo-Hong [2 ]
Tan, Chun-Jiang [3 ]
机构
[1] Shantou Univ, Affiliated Hosp 1, Dept Cardiol, Coll Med, Shantou 515041, Guangdong, Peoples R China
[2] Shantou Univ, Coll Med, Dept Pathol, Shantou 515041, Guangdong, Peoples R China
[3] Fujian Univ TCM, Inst Geriatr Integrated Tradit & Western Med, Fuzhou, Fujian, Peoples R China
关键词
coronary heart disease; expression; heme oxygenase-1; hypoxia inducible factor-1 alpha; ubiquitin; OXIDATIVE STRESS; PROTEASOME PATHWAY; TISSUE HYPOXIA; KAPPA-B; ATHEROSCLEROSIS; INDUCTION; FAILURE; PROTEIN;
D O I
10.1515/CCLM.2009.073
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The increased expression of heme oxygenase-1 content, a stress-response protein, directly correlates with the incidence of coronary heart disease. Down-regulation of hypoxia inducible factor-1 alpha activity, a major downstream effector of the signaling pathways activated by hypoxia, increases cell survival after hypoxia. The ubiquitin system, a non-lysosomal pathway of protein degradation, is involved in processes of coronary heart disease. The aim of this study was to investigate the expression of heme oxygenase-1, hypoxia inducible factor-1 alpha, and ubiquitin in both monocytes and lymphocytes isolated from patients at the mRNA and protein levels in different stages of coronary heart disease and their possible correlation. Methods: A total of 90 patients with coronary heart disease (30 acute myocardial infarction, 30 unstable angina pectoris, and 30 stable angina pectoris) were selected, and 30 cases with normal coronary artery served as controls. The mRNA and protein expression of heme oxygenase-1, hypoxia inducible factor-1 alpha, and ubiquitin in monocytes and lymphocytes were examined by semi-quantitative reverse transcriptase polymerase chain reaction and Western blotting, respectively. Results: The mRNA expression of heme oxygenase-1 and ubiquitin was associated with the severity of coronary heart disease (p<0.05). There was no significant difference in hypoxia inducible factor-1 alpha mRNA expression between the coronary heart disease patients and controls. The protein expression of heme oxygenase-1, hypoxia inducible factor-1 alpha, and ubiquitin was significantly stronger in patients with coronary heart disease than in controls, and the expression levels increased with the severity of the disease. There was a positive association between heme oxygenase-1 and hypoxia inducible factor-1 alpha and ubiquitin, antioxidative therapy with adrenergic receptor blocker, angiotensin-converting enzyme inhibitor or statins up-regulated the expression of heme oxygenase-1 and hypoxia inducible factor-1 alpha. Conclusions: These data suggest that heme oxygenase-1, hypoxia inducible factor-1 alpha, and ubiquitin are involved in the development and progression of coronary heart disease and thus may be useful biomarkers for coronary heart disease.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 28 条
  • [1] Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus
    Arzamastseva, N. E.
    Lankin, V. Z.
    Konovalova, G. G.
    Tikhaze, A. K.
    Ageev, F. T.
    Lapina, V.
    Narusov, O. Yu.
    Mareev, V. Yu.
    Belenkov, Yu. N.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (02) : 207 - 209
  • [2] Study on changes of heme oxygenase-1 expression in patients with coronary heart disease
    Chen, SM
    Li, YG
    Wang, DM
    [J]. CLINICAL CARDIOLOGY, 2005, 28 (04) : 197 - 201
  • [3] Increased malondialdehyde in peripheral blood of patients with congestive heart failure
    DiazVelez, CR
    GarciaCastineiras, S
    MendozaRamos, E
    HernandezLopez, E
    [J]. AMERICAN HEART JOURNAL, 1996, 131 (01) : 146 - 152
  • [4] Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases
    Dudek, EJ
    Shang, F
    Liu, Q
    Valverde, P
    Hobbs, M
    Taylor, A
    [J]. FASEB JOURNAL, 2005, 19 (10) : 1707 - +
  • [5] HIF-1 as a target for drug development
    Giaccia, A
    Siim, BG
    Johnson, RS
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) : 803 - 811
  • [6] Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
    Herrmann, J
    Edwards, WD
    Holmes, DR
    Shogren, KL
    Lerman, LO
    Ciechanover, A
    Lerman, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (11) : 1919 - 1927
  • [7] Ubiquitin-binding domains
    Hicke, L
    Schubert, HL
    Hill, CP
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (08) : 610 - 621
  • [8] Structural basis for the recognition of hydroxyproline in αIF-1α by pVHL
    Hon, WC
    Wilson, MI
    Harlos, K
    Claridge, TDW
    Schofield, CJ
    Pugh, CW
    Maxwell, PH
    Ratcliffe, PJ
    Stuart, DI
    Jones, EY
    [J]. NATURE, 2002, 417 (6892) : 975 - 978
  • [9] Cellular response to tissue hypoxia and its involvement in disease progression
    Ikeda, E
    [J]. PATHOLOGY INTERNATIONAL, 2005, 55 (10) : 603 - 610
  • [10] Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia
    Inamoto, Sakiko
    Hayashi, Tetsuya
    Tazawa, Naoko
    Mori, Tatsuhiko
    Yamashita, Chika
    Nakano, Daisuke
    Matsumura, Yasuo
    Okuda, Nobuaki
    Sohmiya, Koichi
    Sakai, Akiko
    Furuya, Eisuke
    Kitaura, Yasushi
    [J]. CIRCULATION JOURNAL, 2006, 70 (06) : 787 - 792